Companies
From start-ups to market leaders, access critical company intelligence on a global scale
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Experience what our solutions have to offer with free access to highlights of our data, insights and analysis.
From start-ups to market leaders, access critical company intelligence on a global scale
From industry deep dives to global trends, access authoritative research from our experts
Uncover your next opportunity with trusted data & insights that cut across industries
Discover the disruptive forces shaping tomorrow's world, today
Explore our diverse collection of unique datasets and find the advantage you need
Get clarity into the latest emerging themes with our reports
Immuno-Oncology Market Report
GlobalData’s report combines primary research with a cross-specialty I-O KOL panel with in-house analyst expertise to provide a thorough assessment of the marketplace.
GlobalData’s Immuno-Oncology market research report states that it expects innovative trial design and new combination drug approvals to drive market growth. Explore the current status and future challenges of the immuno-oncology market across many indications.
Given durable response is a key unmet need across indications, differentiation of I-O therapies in terms of duration of response and improved survival measures continues to be crucial.
This report delivers primary research with 20 US & EU based KOLs from 8 cancer specialities, as well as providing charts that summarize KOL opinions and identify response patterns. The report also offers key insights from GlobalData’s specialist oncology analysts.